PR4_2009.vp:CorelVentura 7.0 - Institute of Pharmacology
Transkrypt
PR4_2009.vp:CorelVentura 7.0 - Institute of Pharmacology
Pharmacological Reports 2009, 61, 727731 ISSN 1734-1140 Copyright © 2009 by Institute of Pharmacology Polish Academy of Sciences Short communication Synthesis and pharmacological properties of a new fluorescent opioid peptide analog Monika Lukowiak1,2, Piotr Kosson1, Wim E. Hennink2, Andrzej W. Lipkowski1 Medical Research Centre, Polish Academy of Sciences, PL 01-106 Warszawa, Poland Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P.O. Box 80082, 3508 TB Utrecht, The Netherlands Correspondence: Andrzej W. Lipkowski, e-mail: [email protected] Abstract: Biphalin, is a palindromic peptide [(Tyr-D-Ala-Gly-Phe-NH-) ] in which two opioid pharmacophores are connected “tail-to-tail.” This peptide displays a broad affinity for all opioid receptors (m, d and k) as well as exceptionally high antinociceptive activity. Previous structure-activity studies demonstrated that one of the biphalin pharmacophores could be substituted with a hydrophobic group without significant loss of receptor affinity. This paper reports the pharmacological properties of a new analog in which one pharmacophore of biphalin was replaced with fluorescent 7-succinylamido-4-methyl-coumarin. The resulting compound displays an affinity for m opioid receptors that is a d opioid receptor comparable to biphalin but with an affinity that is over a hundred times lower. This m opioid selective fluorescent peptide analog could be applied in pharmacokinetic and pharmacodynamic studies of biphalin related analogs. Key words: biphalin, opioid receptors, fluorescence Pharmacological Reports, 2009, 61, 727731 727